Published in Healthcare Mergers, Acquisitions and Ventures Week, September 20th, 2008
One newly created ad highlights scientific advances that are making the use of human embryonic stem cells obsolete and calls attention to the development of "Induced Pluripotent Stem Cells" (iPSCs). These are virtually identical to embryonic stem cells, derived from ordinary body cells and so can be obtained without destroying human embryos. Picturing a commuter running for a train, the ad asks: "Science is moving on. Isn't it time for public policy to get on board'"
A second ad on...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Healthcare Mergers, Acquisitions and Ventures Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.